Esperion Therapeutics Inc (NAS:ESPR)
$ 2.29 0.12 (5.53%) Market Cap: 433.86 Mil Enterprise Value: 453.51 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Esperion Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2022 / 03:30PM GMT
Release Date Price: $4.13 (+3.51%)
Elias Nicholas Lenard
JPMorgan Chase & Co, Research Division - Research Analyst

Good morning, everyone, and welcome to -- welcome as we continue the 40th Annual JPMorgan Healthcare Conference. My name is Nick Lenard. I'm a biotech analyst here at JPMorgan. I'm joined here today by Esperion's President and CEO, Sheldon Koenig, and other members of management who will provide a presentation of the company, followed by a short Q&A session. (Operator Instructions) I'll receive your questions and be happy to ask management on your behalf.

And now happy to turn it over to Sheldon for the presentation.

Sheldon L. Koenig
Esperion Therapeutics, Inc. - President, CEO & Director

Great. Thank you, Nick. Really appreciate it. It's good to see you today and great to speak to everyone who's attending. On behalf of Esperion Therapeutics, it's our pleasure to have this opportunity to present at the JPMorgan conference. I think we're all ready to head to San Francisco. But hopefully, next year, we'll be doing this live from San Francisco. So thank you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot